About Sangus Life Science Private Limited
Data last updated:
Sangus Life Science Private Limited is a private limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24239BR2017PTC034534. Its GSTIN is 29AAYCS6461L1Z8 (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Chandramani Kumar Jha and Shilpi Kumari.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 444 Pragati Vihar Colony, Patna, Bihar, India – 800027.
As per the financials filed for FY 2022, the company reported a revenue of ₹8.02 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹2.45 Lakh (net margin -30.5%) and EBITDA of -₹1.82 Lakh (EBITDA margin -22.7%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanguslifescience.com.
Company details
Contact details
Sangus Life Science Private Limited's registered office is in Patna, Bihar. Its website is sanguslifescience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address444 Pragati Vihar Colony, Patna, Bihar, India – 800027
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sangus Life Science Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sangus Life Science is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sangus Life Science Private Limited, buy the company report.
Financials of Sangus Life Science Private Limited
FY 2022 filings availableSangus Life Science Private Limited reported revenue of ₹8.02 Lakh (down 12% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 12% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 336% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.45 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -22.7% | ||||
| Net Profit Margin | -30.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sangus Life Science Private Limited, buy the company report.
Board of directors of Sangus Life Science Private Limited
Sangus Life Science has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandramani Kumar Jha | Director | 10 May 2017 | 9 Years 5 Months | Current |
| Shilpi Kumari | Director | 10 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Sangus Life Science Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vijay Shree Chem Drugs Private Limited | ₹8.12 Lakh (FY 2025) | -11.0% | Uttar Pradesh, India | |||
| Med-Ortheve Healthcare Private Limited | ₹8.05 Lakh (FY 2023) | Moshi, Maharashtra, India | ||||
| Sangus Life Science Private Limitedthis company | ₹8.02 Lakh (FY 2022) | -₹2.45 Lakh | -30.5% | -12.0% | Patna, Bihar, India | |
| Midas Care Holdings Pvt Ltd | ₹7.97 Lakh (FY 2017) | -46.0% | Mumbai, Maharashtra, India | |||
| Hetsym Pharma Private Limited | ₹7.92 Lakh (FY 2025) | 75661.0% | Hyderabad, Telangana, India | |||
| Brainichem Formulations Private Limited | ₹7.88 Lakh (FY 2024) | -25.0% | Udhna, Gujarat, India |
To see the full peer comparison of Sangus Life Science Private Limited, buy the company report.
Auditor
Sangus Life Science Private Limited is audited by P BALARAJU & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P BALARAJU & CO | FY 2019 | 015348S |
Shareholding
The shareholding of Sangus Life Science Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Sangus Life Science Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sangus Life Science Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sangus Life Science Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sangus Life Science has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAYCS6461L1Z8 | Karnataka | Active | 04 Nov 2017 |
To see the full GST registrations and return filing status of Sangus Life Science Private Limited, buy the company report.
Recent activity
Sangus Life Science Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Archana Tiwari ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Sangus Life Science is an active private limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 May 2017 (9+ years old) and is registered under CIN U24239BR2017PTC034534.
Sangus Life Science has 2 current directors:
- Chandramani Kumar Jha - Director
- Shilpi Kumari - Director
The latest financial statements of Sangus Life Science on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Sangus Life Science is 29AAYCS6461L1Z8, registered in Karnataka.
The CIN (Corporate Identification Number) of Sangus Life Science is U24239BR2017PTC034534. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sangus Life Science was incorporated on 10 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Sangus Life Science by revenue are Vijay Shree Chem Drugs Private Limited, Med-Ortheve Healthcare Private Limited, Midas Care Holdings Pvt Ltd, Hetsym Pharma Private Limited, Brainichem Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Archana Tiwari ceased to be Additional Director on 30 Sep 2022. Nitesh Kumar ceased to be Additional Director on 30 Sep 2022. Chandramani Kumar Jha was appointed as Director on 10 May 2017. Sangus Life Science has 4 board changes on record in total.
Sangus Life Science can be reached through the website sanguslifescience.com. Its registered office is in Patna, Bihar, India.
The registered office of Sangus Life Science is at 444 Pragati Vihar Colony, Patna, Bihar, India – 800027.
Sangus Life Science operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
